Validated five-factor model of Positive and Negative Syndrome Scale for schizophrenia in Chinese population
Introduction
Positive and Negative Syndrome Scale (PANSS) is one of the most widely used instruments to measure the severity of schizophrenia. In the instrument, a total of 30 items were designed to assess the severity of three prior dimensions of the symptoms: positive syndrome (7 items), negative syndrome (7 items), and general psychopathology (16 items) (Kay et al., 1987). However, Kay and Sevy (1990) later found that the 30 items measured four factors of symptoms by examining the eigenvalue of PANSS. This 4-factor model was named as pyramidical model, and the factors were positive factor, negative factor, excitement factor, and depression factor. Since then, different structures of PANSS have been reported. Peralta and Cuesta (1994) found that the positive and negative factors could be further deconstructed into three independent dimensions: positive, disorganized, and negative symptoms, suggesting a five-factor model of PANSS. Van den Oord et al. (2006) found that six-factor model, which included an additional “withdraw” dimension of symptoms, could fit the observed PANSS data better. Seven-factor model has also been reported by employing exploratory factor analysis of PANSS scores (Emsley et al., 2003).
In spite of the variety of factor models reported, five-factor model of PANSS is the most commonly reported and adopted model in literature (Lehoux et al., 2009). In the model, selected items of PANSS are grouped based on their correlations into five dimensions, which are named as positive factor, negative factor, cognitive factor, excitement factor and depression factor. Although this way of deconstruction of schizophrenia symptomatology is generally accepted, controversies come when deciding which items shall be assigned to each of the five dimensions. Different studies usually report different types of five-factor models, and no model has reached broad congruence to date. Wallwork et al. (2012) have attempted to build a consensus model by assigning only the consistent PANSS items to each of the five factors based on previously published models. The good fit of the model on their dataset and an independent validation dataset suggests that a better model could be achieved by considering the consensus items in previously published models.
The lack of consistency in the specific forms of five-factor model has been partially attributed to methodological reasons, such as factors with cross-loading are not included in constructing the model (Van den Oord et al., 2006). However, by including cross-loading items, the independence of the factors and the fits of the models might be compromised. A lack of validation of the derived model in an independent study sample may also contribute to the inconsistency. We have reviewed a total of 30 published articles on PANSS since 1990, among which only few have validated the models in an independent study population. Applying the model on the same dataset from which the model is derived tends to yield good fits, but the generalizability is not guaranteed (van der Gaag et al., 2006a). Thirdly, cultural difference may also affect clinical presentations. Studies have found that Asian patients with schizophrenia are more likely to show auditory hallucination, neglect of activities, loss of appetite, be irritable and more likely to get family supports (Krajewski-Jaime, 1991, Bhugra et al., 1999, Mass et al., 2000, Versola-Russo, 2006). These cultural impacts could possibly introduce variations in the apparent structure of PANSS across studies. Lastly, difference in ethnicity also influences the way of clinical presentation (Lim et al., 2011), which implies that the factor structure of PANSS may also be affected by ethnic difference. In addition, among the 30 reviewed articles, only three are based on Asian population (Kawasaki et al., 1994, Higashima et al., 1998, Kim et al., 2012) and no study has been performed on Chinese population, suggesting that more studies on Asian population are needed to balance the view of the structure of PANSS.
The aim of this study was to investigate the structure of PANSS of Chinese schizophrenia population. To enhance the validity and generalizability of the factor model, we employed two large independent study samples, built a confirmatory factor analysis (CFA) model based on the factor loadings of exploratory factor analysis (EFA) from one sample, and validated the model on the other independent study sample. In constructing the CFA model, we also took into account of 32 previously published models such that only the consensus items were assigned to a factor. The results of this study could help in understanding the structure of the symptomatology of schizophrenia and could also serve as a reference for future studies on PANSS in Chinese schizophrenia population.
Section snippets
Study samples
Two study samples were used in identification and validation of the factor structure of PANSS of Chinese schizophrenia patients. The first study sample comprised 903 schizophrenia patients recruited in the Institute of Mental Health of Singapore between 2005 and 2008. Patients were included if they were Chinese and if they met SCID-DSM-IV schizophrenia diagnostic criteria. Patients were excluded from the study if they had organic brain disorder or mental retardation. Ethics approvals for the
Descriptive statistics of study samples
The descriptive statistics of the study samples are shown in Table 1. Patients in the validation sample were younger than patients in the exploratory sample, but they have more severe symptoms. The proportion of males in the validation sample was also higher than the proportion in the exploratory sample. No PANSS scores were missing in the exploratory sample, and 0.36% of PANSS scores was missing in the validation study sample.
Determination of the number of factors
We examined the exploratory study sample by fitting the data with 3
Discussion
The aim of this study was to elucidate the factor structure of PANSS of Chinese schizophrenia patients. EFA on the exploratory dataset suggested that there were five factors underlying the multi-dimensional symptomatology of schizophrenia. This finding is in agreement with many previous studies showing that PANSS consisted of five dimensions of schizophrenia symptomatology (van der Gaag et al., 2006a). However, none of the previously published five-factor model fits both of our study samples.
Role of funding source
Funding for this study was provided by the National Research Foundation Singapore.
Contributors
Dr. Lee and Dr. Sim designed the study and wrote the protocol. Jiang Jundong managed the literature searches and analyses, and wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript.
Conflict of interest
None.
Acknowledgments
The Singapore Translational and Clinical Research in Psychosis is supported by the National Research Foundation Singapore under the National Medical Research Council Translational and Clinical Research Flagship Programme (Grant No.: NMRC/TCR/003/2008).
References (41)
- et al.
Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale
Psychiatry Res.
(1994) - et al.
Efficacy of iloperidone in schizophrenia: a PANSS five-factor analysis
Schizophr. Res.
(2011) - et al.
Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase
Eur. Psychiatry
(1995) - et al.
The evolution of symptoms in the early course of non-affective psychosis
Schizophr. Res.
(2003) - et al.
Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia
Schizophr. Res.
(2002) - et al.
The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis
Schizophr. Res.
(2003) - et al.
A confirmatory factor analytic evaluation of the pentagonal PANSS model
Schizophr. Res.
(2003) - et al.
A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients
Schizophr. Res.
(2005) - et al.
P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia
Biol. Psychiatry
(1998) - et al.
Evaluation of the factor structure of symptoms in patients with schizophrenia
Psychiatry Res.
(2012)
Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS)
Schizophr. Res.
Five factor model of schizophrenia: replication across samples
Schizophr. Res.
Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia
Psychiatry Res.
Factor structure and external validity of the PANSS revisited
Schizophr. Res.
The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions
Schizophr. Res.
The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model
Schizophr. Res.
Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia
Schizophr. Res.
Early manifestations, personality traits and pathways into care for Asian and white first-onset case of schizophrenia
Soc. Psychiatry
Symptom dimensions in the course of childhood-onset schizophrenia
Eur. Child Adolesc. Psychiatry
PANSS symptom factors in schizophrenia
Schizophr. Res.
Cited by (58)
Defining negative symptoms remission in schizophrenia using the Brief Negative Symptom Scale
2022, Revista de Psiquiatria y Salud MentalCitation Excerpt :Each item was rated on a Likert scale from 1 (absent) to 7 (extreme). A 5-factor structure of the PANSS was validated in Singapore; the factors were: positive, negative, excitement, depression and cognitive.37 The BNSS was used to evaluate the presence and severity of NS in schizophrenia.
Large-scale evaluation of the Positive and Negative Syndrome Scale (PANSS) symptom architecture in schizophrenia
2021, Asian Journal of PsychiatryCitation Excerpt :Factor analytic studies in PANSS provide an avenue to establish measurable dimensional constructs in individuals with psychosis, which dovetails increasing efforts to study the dimensionality of psychopathology (Cuthbert, 2014). Exploratory Factor Analysis (EFA) on PANSS items (Jiang et al., 2013; Wallwork et al., 2012), facilitated symptom definition of psychopathology in schizophrenia. We had previously reported the possibility of further breaking down the definition of such symptom domains to evaluate subtler aspects of schizophrenia symptoms (Lam et al., 2015; Lim et al., 2016).
Association between negative symptom domains and happiness in schizophrenia
2021, General Hospital PsychiatryClinical utility of the Negative Symptom Assessment-16 in individuals with schizophrenia
2019, European Neuropsychopharmacology